(Q20817068)

(Redirected from Q76393584)
English

halobetasol propionate

pharmaceutical drug

  • SID50112705
  • Miracorten
  • ulobetasol propionate
  • (6α,8ξ,10ξ,13ξ,14ξ,16β)-21-Chloro-6,9-difluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl propionate

Statements

1 reference
Halobetasol Propionate (English)
17 November 2015
Ulobetasol propionate.svg
1,485 × 1,135; 31 KB
0 references
484.182808±0 dalton
1 reference
C₂₅H₃₁ClF₂O₅
1 reference
CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
1 reference
CCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)CCl
0 references

Identifiers

1 reference
(6alpha,8xi,10xi,13xi,14xi,16beta)-21-Chloro-6,9-difluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl propionate (English)
20 September 2016
0 references
686-247-0
1 reference
27 December 2018
Halobetasol Propionate (English)
CAS no.: 66852-54-8 (English)
1 reference
27 December 2018
Halobetasol Propionate (English)
CAS no.: 66852-54-8 (English)
1 reference
Halobetasol Propionate (English)
17 November 2015
1 reference
HALOBETASOL PROPIONATE (English)
19 January 2016
1 reference
HALOBETASOL PROPIONATE (English)
19 January 2016
0 references
 
edit
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit